The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

The collaboration aims to reduce the production costs of gene therapy medicines by harnessing Eukarÿs' proprietary C3P3 technology, an innovative messenger RNA (mRNA) expression system in mammalian ...

It is possible that Moderna's experience with artificial intelligence and proprietary digital technologies could allow it to design the best mRNA sequences for protein expression, and pandemic ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station.

HNRNPC, known for its role in pre-mRNA splicing, was found to enhance the inclusion ... the researchers analyzed the ...